NEW YORK (GenomeWeb) – Horizon Discovery today announced a deal for the marketing of its X-MAN human haploid and diploid isogenic cell line collection by Thermo Fisher Scientific. 

Under the supply and commercialization agreement, Thermo Fisher will also further offer Horizon's X-MAN haploid cell line generation service to its worldwide customer base. Thermo Fisher will use its e-commerce and direct sales channels to make the products and services available to the research community. 

Financial and other terms were not disclosed. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.